A
Live / Registered — Registered — Section 71 accepted (as of 28 Jun 2024)
What this means for you
Registered since 12 Jun 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 12 Jun 2028: the §71 ten-year affidavit of use).
Record
- Serial number
- 79201245
- Registration number
- 5488639
- Mark type
- Design + words
- Filed
- 16 Nov 2016
- Published for opposition
- 27 Mar 2018
- Registered
- 12 Jun 2018
- Next maintenance filing
- §71 ten-year affidavit of use, due by 12 Jun 2028 (grace period to 12 Dec 2028)
- Attorney of record
- Linda Joy Kattwinkel
Goods and services
- Class 005 — Pharmaceuticals: PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY FOR THE TREATMENT OF OSTEOARTHRITIS, NEUROLOGIC CONDITIONS, INFLAMMATORY CONDITIONS, IMMUNE-MEDIATED CONDITIONS, ENDOCRINE DISEASES, CHRONIC DEGENERATIVE DISEASES, GASTROINTESTINAL DISEASES; PHARMACEUTICAL PREPARATIONS FOR GENE THERAPY FOR THE TREATMENT OF GENETIC DISEASES OR DISORDERS; PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF GENE THERAPY TREATABLE DISEASES, NAMELY, OSTEOARTHRITIS, NEUROLOGIC CONDITIONS, INFLAMMATORY CONDITIONS, IMMUNE-MEDIATED CONDITIONS, ENDOCRINE DISEASES, CHRONIC DEGENERATIVE DISEASES, GASTROINTESTINAL DISEASES; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISORDERS OF THE NERVOUS SYSTEM, THE IMMUNE SYSTEM, THE CARDIO-VASCULAR SYSTEM, THE METABOLIC SYSTEM, THE RESPIRATORY SYSTEM, THE MUSCULO-SKELETAL SYSTEM, THE OCULAR AND AUDITORY SYSTEMS, AND THE GENITOURINARY SYSTEM
Owner
- Adverum Biotechnologies, Inc., DE, US
- Adverum Biotechnologies, Inc., DE, US
- Adverum Biotechnologies, Inc., DE, US
Prosecution history
- 04 Jun 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 28 Jun 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 28 Jun 2024 — REGISTERED-SEC.71 ACCEPTED
- 21 May 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Sept 2023 — TEAS SECTION 71 RECEIVED
- 12 Jun 2023 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 04 Feb 2023 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 20 Jan 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 12 Oct 2018 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 21 Sept 2018 — FINAL DISPOSITION NOTICE SENT TO IB
- 20 Sept 2018 — FINAL DISPOSITION PROCESSED
- 12 Sept 2018 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 12 Jun 2018 — REGISTERED-PRINCIPAL REGISTER
- 27 Mar 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Mar 2018 — PUBLISHED FOR OPPOSITION